Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD
Gerard J. Criner(Temple Lung Center), Stephen C. Lazarus(University of California, San Francisco), Frank C. Sciurba(University of Pittsburgh), Don D. Sin(St. Paul's Hospital), Mark T. Dransfield(University of Alabama at Birmingham), Jeffrey L. Curtis(University of Michigan), Barry J. Make, Richard Casaburi, Shawn D. Aaron(Ottawa Hospital), Nathaniel Marchetti, George R. Washko(Brigham and Women's Hospital), Prescott G. Woodruff(University of California, San Francisco), Steven M. Scharf(University of Maryland, Baltimore), John A. Cooper, John E. Connett(University of Minnesota System), Fernando J. Martínez(University of Michigan–Ann Arbor), Paul D. Scanlon(Mayo Clinic), Helen Voelker(University of Minnesota System), Dennis E. Niewoehner, Richard Albert(Denver Health Medical Center), William C. Bailey(University of Alabama at Birmingham), MeiLan K. Han(University of Michigan)
Cited by 346
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2013|3.8k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k